Compounds > 4-aminoquinoline
Page last updated: 2024-08-24

4-aminoquinoline and Porphyria Cutanea Tarda

4-aminoquinoline has been researched along with Porphyria Cutanea Tarda in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, KE; Kuo, YF; Rizwan, M; Salameh, H; Sarairah, H; Singal, AK1
Singal, AK1

Reviews

2 review(s) available for 4-aminoquinoline and Porphyria Cutanea Tarda

ArticleYear
Relapse of porphyria cutanea tarda after treatment with phlebotomy or 4-aminoquinoline antimalarials: a meta-analysis.
    The British journal of dermatology, 2018, Volume: 179, Issue:6

    Topics: Aminoquinolines; Antimalarials; Dose-Response Relationship, Drug; Humans; Phlebotomy; Porphyria Cutanea Tarda; Recurrence; Treatment Outcome

2018
Porphyria cutanea tarda: Recent update.
    Molecular genetics and metabolism, 2019, Volume: 128, Issue:3

    Topics: Aminoquinolines; Animals; Carcinoma, Hepatocellular; Genetic Predisposition to Disease; Humans; Liver; Liver Neoplasms; Mice; Mutation; Neoplasm Recurrence, Local; Observational Studies as Topic; Phlebotomy; Porphyria Cutanea Tarda; Recurrence; Risk Factors; Uroporphyrinogen Decarboxylase

2019